相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Role of 89Zr-Immuno-PET in Navigating and Derisking the Development of Biopharmaceuticals
Guus A. M. S. van Dongen et al.
JOURNAL OF NUCLEAR MEDICINE (2021)
The ancillary effects of nanoparticles and their implications for nanomedicine
Evan P. Stater et al.
NATURE NANOTECHNOLOGY (2021)
The entry of nanoparticles into solid tumours
Shrey Sindhwani et al.
NATURE MATERIALS (2020)
Intratumoral Comparison of Nanoparticle Entrapped Docetaxel (CPC634) with Conventional Docetaxel in Patients with Solid Tumors
Florence Atrafi et al.
CLINICAL CANCER RESEARCH (2020)
Polymeric Nanoparticles with Neglectable Protein Corona
Irina Alberg et al.
SMALL (2020)
Optical imaging of the whole-body to cellular biodistribution of clinical-stage PEG-b-pHPMA-based core-crosslinked polymeric micelles
Ilaria Biancacci et al.
JOURNAL OF CONTROLLED RELEASE (2020)
A phase I dose-escalation and pharmacokinetic study of a micellar nanoparticle with entrapped docetaxel (CPC634) in patients with advanced solid tumours
Florence Atrafi et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Recent Clinical Developments of Nanomediated Drug Delivery Systems of Taxanes for the Treatment of Cancer
Ruben A. G. van Eerden et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2020)
Metastatic castration-sensitive prostate cancer: Abiraterone, docetaxel, or ...
Pedro C. Barata et al.
CANCER (2019)
Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer A Phase 2 Clinical Trial
Janet E. Murphy et al.
JAMA ONCOLOGY (2019)
Smart cancer nanomedicine
Roy van der Meel et al.
NATURE NANOTECHNOLOGY (2019)
Tumor targeting via EPR: Strategies to enhance patient responses
Susanne K. Golombek et al.
ADVANCED DRUG DELIVERY REVIEWS (2018)
Does PET Reconstruction Method Affect Deauville Scoring in Lymphoma Patients?
Ronald Boellaard et al.
JOURNAL OF NUCLEAR MEDICINE (2018)
A new method for the determination of total and released docetaxel from docetaxel-entrapped core-crosslinked polymeric micelles (CriPec®) by LC-MS/MS and its clinical application in plasma and tissues in patients with various tumours
C. L. Braal et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2018)
Comparison of the octadentate bifunctional chelator DFO*-pPhe-NCS and the clinically used hexadentate bifunctional chelator DFO-pPhe-NCS for 89Zr-immuno-PET
Danielle J. Vugts et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2017)
64Cu-MM-302 Positron Emission Tomography Quantifies Variability of Enhanced Permeability and Retention of Nanoparticles in Relation to Treatment Response in Patients with Metastatic Breast Cancer
Helen Lee et al.
CLINICAL CANCER RESEARCH (2017)
Correlation between Ferumoxytol Uptake in Tumor Lesions by MRI and Response to Nanoliposomal Irinotecan in Patients with Advanced Solid Tumors: A Pilot Study
Ramesh K. Ramanathan et al.
CLINICAL CANCER RESEARCH (2017)
Tailoring the physicochemical properties of core-crosslinked polymeric micelles for pharmaceutical applications
Qizhi Hu et al.
JOURNAL OF CONTROLLED RELEASE (2016)
To exploit the tumor microenvironment: Since the EPR effect fails in the clinic, what is the future of nanomedicine?
F. Danhier
JOURNAL OF CONTROLLED RELEASE (2016)
Complete regression of breast tumour with a single dose of docetaxel-entrapped core-cross-linked polymeric micelles
Qizhi Hu et al.
BIOMATERIALS (2015)
Inter-patient variability in docetaxel pharmacokinetics: A review
Annemieke J. M. Nieuweboer et al.
CANCER TREATMENT REVIEWS (2015)
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Ronald Boellaard et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2015)
Multicenter Harmonization of 89Zr PET/CT Performance
Nikolaos E. Makris et al.
JOURNAL OF NUCLEAR MEDICINE (2014)
Presentation and management of docetaxel-related adverse effects in patients with breast cancer
Maria Y. Ho et al.
CANCER MANAGEMENT AND RESEARCH (2014)
Toward Prediction of Efficacy of Chemotherapy: A Proof of Concept Study in Lung Cancer Patients Using [11C]docetaxel and Positron Emission Tomography
Astrid A. M. van der Veldt et al.
CLINICAL CANCER RESEARCH (2013)
被撤回的出版物: World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects (Retracted article. See vol. 135, pg. 2149, 2021)
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial
Athanassios Argiris et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Factors controlling the pharmacokinetics, biodistribution and intratumoral penetration of nanoparticles
Mark J. Ernsting et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Comparison of liposomal cisplatin versus cisplatin in non-squamous cell non-small-cell lung cancer
G. P. Stathopoulos et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Core-crosslinked polymeric micelles with controlled release of covalently entrapped doxorubicin
Marina Talelli et al.
BIOMATERIALS (2010)
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. A. Eisenhauer et al.
EUROPEAN JOURNAL OF CANCER (2009)
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer: Updated survival in the TAX 327 study
Dominik R. Berthold et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Phase III study of second-line chemotherapy for advanced non-small-cell lung cancer with weekly compared with 3-weekly docetaxel
W Schuette et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer
WJ Gradishar et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
分享论文
